The HLA-G/ILT2 pathway modulates CD8 T cell effector function in gastric cancer

被引：0
|
作者：
Vaquero Yuste, Christian [1 ]
Molina Alejandre, Marta [1 ]
Juarez, Ignacio [1 ]
Gonzalo Jimenez, Diego Jose [1 ]
Gutierrez Calvo, Alberto [2 ]
Lopez Garcia, Adela [2 ]
Gomez Sanz, Remedios [2 ]
Fernandez Cruz, Eduardo [3 ]
Rodriguez Sainz, Carmen [3 ]
Arnaiz Villena, Antonio [1 ]
Martin Villa, Jose Manuel [1 ]
机构：
[1] Univ Complutense Madrid, Fac Med, Dept Immunol Oftalmol & ORL, Madrid, Spain
[2] Hosp Univ Principe de Asturias, Madrid, Spain
[3] Hlth Res Inst Gregorio Maranon, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Biomarkers; cancer immunology; checkpoint inhibition; immune regulation and therapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-0896
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [31] ILT2/LIR1 inhibitory receptor, a new marker for cytotoxic CD8+ T cells, regulates cytotoxic T cell function
    Yamashita, Y
    Amasaki, Y
    Yamashita, T
    Ichikawa, K
    Atsumi, T
    Koike, T
    FASEB JOURNAL, 2002, 16 (04): : A316 - A316
  • [32] Anti-LAG-3 boosts CD8 T cell effector function
    Kureshi, Courtney T.
    Dougan, Michael
    Dougan, Stephanie K.
    CELL, 2024, 187 (16)
  • [33] Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function
    Scharer, Christopher D.
    Barwick, Benjamin G.
    Youngblood, Benjamin A.
    Ahmed, Rafi
    Boss, Jeremy M.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (06): : 3419 - 3429
  • [34] Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer
    Chen, Qiong-Yuan
    Zhou, Wen-Jun
    Zhang, Jiang-Gang
    Zhang, Xia
    Han, Qiu-Yue
    Lin, Aifen
    Yan, Wei-Hua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109
  • [35] Effector CD8 T cell trafficking within the liver
    Guidotti, Luca G.
    Iannacone, Matteo
    MOLECULAR IMMUNOLOGY, 2013, 55 (01) : 94 - 99
  • [36] Origin of CD8~+ Effector and Memory T Cell Subsets
    Christian Stemberger
    Michael Neuenhahn
    Veit R.Buchholz
    Dirk H.Busch
    Cellular & Molecular Immunology, 2007, (06) : 399 - 405
  • [37] CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
    Dumont, Clement
    Jacquier, Alix
    Verine, Jerome
    Noel, Floriane
    Goujon, Annabelle
    Wu, Ching-Lien
    Hung, Tzu-Min
    Desgrandchamps, Francois
    Culine, Stephane
    Carosella, Edgardo D.
    Rouas-Freiss, Nathalie
    LeMaoult, Joel
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (10) : 1619 - 1632
  • [38] The Notch signaling pathway: a new mastor regulator of effector CD8 T cell differentiation
    Duval, Frederic Antoine
    Mathieu, Melissa
    Daudelin, Jean-Francois
    Labrecque, Nathalie
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [39] Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
    Lefebvre, S
    Antoine, MT
    Uzan, S
    McMaster, M
    Dausset, J
    Carosella, ED
    Paul, P
    JOURNAL OF PATHOLOGY, 2002, 196 (03): : 266 - 274
  • [40] Enhanced expression of the inhibitory receptor CD85j/ILT2 on antigen-specific CD8 T cells in HIV infection.
    Ince, N
    Harnisch, B
    Xu, Z
    Lee, SK
    Lieberman, J
    BLOOD, 2001, 98 (11) : 785A - 786A
12345